Physician
Maisonet, Laddy
Maisonet, Laddy was paid $1.90M by Medicaid between Jan 2018 and Mar 2023, across 46 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoMAISONET, LADDY
PEABODY, MA 01960
PEABODY, MA 01960
33aNPI1407198831assigned 03/24/2013
33bProvider typePediatrics Physician
28Total paid$1.90M
24GClaims53,503
24DCodes billed46
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#25 of 1,273
Median peer was paid$24K
This provider vs. median79×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,419 | $255K | |
| 2019 | 10,564 | $358K | |
| 2020 | 10,195 | $341K | |
| 2021 | 11,777 | $405K | |
| 2022 | 11,600 | $459K | |
| 2023 | 1,948 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 3,957 | 3,729 | $370K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 6,820 | 5,446 | $232K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 4,399 | 4,280 | $231K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.2% | 2,080 | 2,080 | $174K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.8% | 1,855 | 1,843 | $149K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 1,605 | 1,605 | $134K |
| 90461 | 5.1% | 2,488 | 2,481 | $96K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 1,598 | 1,590 | $82K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.1% | 6,561 | 6,550 | $59K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.8% | 576 | 576 | $52K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.7% | 4,435 | 4,295 | $51K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.8% | 1,338 | 1,330 | $34K |
34 more codes
| 99188 | 1.6% | 1,192 | $31K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 4,071 | $30K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 330 | $25K |
| 96127 | 1.2% | 2,236 | $23K | |
| 99177 | 1.2% | 1,287 | $23K | |
| 36416 | 1.0% | 1,926 | $19K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 115 | $15K |
| 83655 | <1% | 1,024 | $12K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 389 | $12K |
| 80061 | Lipid panel | <1% | 713 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 240 | $5K |
| 0071A | <1% | 71 | $3K | |
| 0072A | <1% | 70 | $3K | |
| 99050 | <1% | 181 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 82 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 82 | $2K |
| 0001A | <1% | 46 | $2K | |
| 99051 | <1% | 126 | $2K | |
| 0002A | <1% | 38 | $2K | |
| 87634 | <1% | 20 | $1K | |
| 92587 | <1% | 44 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 452 | $1K |
| 94760 | <1% | 403 | $892.54 | |
| 99173 | <1% | 39 | $866.58 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 56 | $661.36 |
| 0124A | <1% | 13 | $596.44 | |
| 81003 | <1% | 254 | $533.35 | |
| 83718 | <1% | 60 | $507.00 | |
| 0054A | <1% | 13 | $455.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 18 | $425.16 |
| 82465 | <1% | 60 | $268.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $228.90 |
| 87081 | <1% | 28 | $191.52 | |
| 99000 | <1% | 97 | $97.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.